Aarti Drugs is currently trading at Rs. 645.20, up by 2.60 points or 0.40% from its previous closing of Rs. 642.60 on the BSE.
The scrip opened at Rs. 650.00 and has touched a high and low of Rs. 659.05 and Rs. 644.80 respectively. So far 11219 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1025.00 on 08-Oct-2020 and a 52 week low of Rs. 105.56 on 19-Mar-2020.
Last one week high and low of the scrip stood at Rs. 686.35 and Rs. 638.55 respectively. The current market cap of the company is Rs. 6026.31 crore.
The promoters holding in the company stood at 60.20%, while Institutions and Non-Institutions held 4.74% and 35.07% respectively.
Aarti Drugs has been closed its Wholly Owned Subsidiary Company namely ‘Pinnacle Life Science LLC’. Further, it was not a material subsidiary of the company and did not have any business activity. The wounding-up of this subsidiary will not affect the revenue or business of the company due to nil business activity of this subsidiary.
Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.
